Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...
Vous n'êtes pas connecté
According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation (an inherited change in BRCA genes that significantly increases the risk of developing certain cancers, especially breast cancer), do not face an increased risk of recurrence or developing new breast cancers. “Our [...]
Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...
Certain vitamin deficiencies may signal an increased risk of cancer. Low levels of vitamins C, A, and D, as well as the trace mineral selenium, have...
University of Oregon biologists have uncovered a mechanism by which a well-known breast cancer gene also influences fertility. Mutations in the BRCA1...
Drugs designed to target HER2-positive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial...
THURSDAY, Nov. 7, 2024 -- Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new...
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to...
SPRING, Texas, Nov. 08, 2024 (GLOBE NEWSWIRE) — Io Therapeutics, Inc., presented results from studies done in breast, colorectal, and prostate...
An infectious diseases expert has raised eyebrows after she successfully treated her own breast cancer by injecting her tumour with viruses grown in...
A small clinical trial has shown encouraging outcomes for patients with triple-negative breast cancer who were treated with an experimental vaccine...
Research links cannabis use to a higher cancer risk, especially lung and testicular cancers, due to smoke inhalation and carcinogens. Moderation...